NIH: Continuation of Cure Glomerulonephropathy (CureGN) Participating Clinical Centers (U01 Clinical Trial Not Allowed)RFA-DK-18-503
Sponsor: NIHInternal Deadline: 09/17/2018Institutional Submission Limit: 1Sponsor Deadline: 10/21/2018Program WebsiteNIH: Continuation of Cure Glomerulonephropathy (CureGN) Participating Clinical Centers (U01 Clinical Trial Not Allowed)RFA-DK-18-503
This FOA encourages applications that facilitate extend the Cure Glomerulonephropathy (CureGN) Network by continuing to support the Participating Clinical Centers (PCCs). The CureGN Network is a multicenter observational cohort study of glomerular disease patients with the goal of improving care for all glomerular disease patients. The operational components of the study include four multi-site PCCs and a Data Coordinating Center (DCC).
USC may only submit only one application in response to this program announcement. Your application submission MUST be coordinated with the Office of the Vice President for Research. Please send a two page abstract via email to Richard White (email@example.com) by September 17, 2018. In addition to the 2-page abstract, you should also submit a biosketch for the PI.
NIH indicates that a letter of intent is due by October 21, 2018 and a completed application is due by November 21, 2018. For more information: https://grants.nih.gov/grants/guide/rfa-files/RFA-DK-18-503.html